Find Federal Grants
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
National Institutes of Health · PAR-24-063
HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
National Institutes of Health · RFA-NS-24-019
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
National Institutes of Health · PAR-23-295
Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
National Institutes of Health · PAR-23-294
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
National Institutes of Health · PAR-23-293
Long-Acting Drug Delivery Systems for ART Optimization in Children Living with HIV-1 II (LADDS II) (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health · RFA-AI-23-061
Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-24-046
Down Syndrome Clinical Cohort Coordinating Center (DS-4C) for the INCLUDE Project (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) (U54 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-24-005
Federated Biobanking resource for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-24-004
Down Syndrome Cohort Research Sites (DS-CRS) for the Down Syndrome Cohort Study Program (DS-CDP) across the lifespan for the INCLUDE Project (U01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-OD-24-003
Understanding the Impact of Healthcare System and Clinician Factors on Disparities in Maternal Morbidity and Mortality (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-24-059
HEAL Initiative: Limited Competition: Clinical Centers for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (UG1 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-24-014
HEAL Initiative: Limited Competition: Data Coordinating Center for Completion of the Outcomes of Babies with Opioid Exposure (OBOE) Study (U24 Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-24-015
Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
National Institutes of Health · PAR-24-045
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R2-0090
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R7-0092
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R1-0099
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R1-0100
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R1-0101
Administration for Children and Families - OHS · HHS-2024-ACF-OHS-CH-R8-0112